Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer

QF Han, WJ Li, KS Hu, J Gao, WL Zhai, JH Yang… - Molecular cancer, 2022 - Springer
Exosomes are well-known key mediators of intercellular communication and contribute to
various physiological and pathological processes. Their biogenesis involves four key steps …

The role of ubiquitination in tumorigenesis and targeted drug discovery

L Deng, T Meng, L Chen, W Wei, P Wang - Signal transduction and …, 2020 - nature.com
Ubiquitination, an important type of protein posttranslational modification (PTM), plays a
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …

Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics

AM Antao, A Tyagi, KS Kim, S Ramakrishna - Cancers, 2020 - mdpi.com
Since the discovery of the ubiquitin proteasome system (UPS), the roles of ubiquitinating
and deubiquitinating enzymes (DUBs) have been widely elucidated. The ubiquitination of …

Poly (2‐oxazoline)‐and Poly (2‐oxazine)‐Based Self‐Assemblies, Polyplexes, and Drug Nanoformulations—An Update

A Zahoranová, R Luxenhofer - Advanced Healthcare Materials, 2021 - Wiley Online Library
Abstract For many decades, poly (2‐oxazoline) s and poly (2‐oxazine) s, two closely related
families of polymers, have led the life of a rather obscure research topic with only a few …

Targeting the ubiquitin-proteasome system for cancer therapeutics by small-molecule inhibitors

G LaPlante, W Zhang - Cancers, 2021 - mdpi.com
Simple Summary The ubiquitin-proteasome system regulates multiple facets of protein
homeostasis to modulate signal transduction in numerous biological processes. Not …

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

M Mondal, D Conole, J Nautiyal, EW Tate - British journal of cancer, 2022 - nature.com
Breast cancer has the highest incidence and death rate among cancers in women
worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and …

Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating enzyme UCHL1, with antifibrotic activity

N Panyain, A Godinat, T Lanyon-Hogg… - Journal of the …, 2020 - ACS Publications
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a deubiquitylating enzyme that is
proposed as a potential therapeutic target in neurodegeneration, cancer, and liver and lung …

The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma

X Wang, J Guo, P Yu, L Guo, X Mao, J Wang… - Journal of Experimental …, 2021 - Springer
Head and neck squamous cell carcinoma (HNSCC) is one of the main malignant tumours
affecting human health, mainly due to delayed diagnosis and high invasiveness …

Targeting the ubiquitin–proteasome system and recent advances in cancer therapy

D Spano, G Catara - Cells, 2023 - mdpi.com
Ubiquitination is a reversible post-translational modification based on the chemical addition
of ubiquitin to proteins with regulatory effects on various signaling pathways. Ubiquitination …

[HTML][HTML] Treating Cancer through Modulating Exosomal Protein Loading and Function: The Prospects of Natural Products and Traditional Chinese Medicine

L Meng, C Zhang, P Yu - Pharmacological Research, 2024 - Elsevier
Exosomes, small yet vital extracellular vesicles, play an integral role in intercellular
communication. They transport critical components, such as proteins, lipid bilayers, DNA …